Major Depressive Disorder Clinical Trial
Official title:
Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors - a Feasibility Study
The study is designed to answer the following research questions:
1. Evaluate the acceptability of mental health screening and of the instruments used in a
sample of community living Chinese seniors;
2. Determine rates of mental health service utilization in individuals identified at
screening as having psychological disturbance;
3. Determine if identifying mental illness and informing participants of screening results
and with treatment alternatives alters help-seeking pathways.
The study hypotheses are:
1. This community sample of Chinese seniors will show a higher prevalence of psychological
disturbance than their counterparts in the general population;
2. Emotional well-being will be positively correlated with individuals' physical health
and social support network.
A convenience sample will be drawn from 6 Congregate Dining (CD) groups in the Chinese
community. There are six groups of CD programs run by Yee Hong Centre for Geriatric Care run
at different locations in the Greater Toronto Area. The screening will be offered on site at
regular CD meetings to participants who have given informed, written consent. All
participants will attend a private post-screening interview. Those who score above the
threshold for depression and/or cognitive impairment, and who have not previously been
diagnosed or treated for these conditions, will be randomly assigned to one of two groups:
an intervention group and a usual care group. Participants in the intervention group will
receive their screening results at the post-screening interviews and will also be provided
with suggestions for possible follow-up. They will be given the option of receiving further
psychiatric assessment at the Wellness Centre, or seeking care with their family physician
and assisted to obtain further care, if desired. Participants in the intervention group will
attend an appointment 3 months after receiving screening results and follow-up options
during which the rate of help seeking, rate of confirmed psychiatric diagnoses and types of
intervention received will be determined. Participants in the usual care group will not be
given screening results at the post-screening interview but will instead attend an
appointment 3 months post screening to receive their results and information about follow-up
options.
The results of this research will: demonstrate whether community living Chinese elders are
at greater risk of psychiatric disorders and demonstrate the need for screening in older
Chinese adults living in the community; aid in the development of systematic and targeted
community-based screening and outreach to at-risk members of the target population; and help
determine if identification of mental health issues and education about treatment resources
has any effect on help-seeking for those conditions.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Screening
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A | |
Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 |